Ketamine regulates the presynaptic release machinery in the hippocampus

Journal of Psychiatric Research

Volumn 47, Issue 7, 2013, Pages 892-899

  Müller, Heidi Kaastrup ^a   Wegener, Gregers ^a   Liebenberg, Nico ^a   Zarate, Carlos A ^b   Popoli, Maurizio ^c   Elfving, Betina ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Antidepressant; CaMKII; Ketamine; SNARE; Synapsin; Synaptotagmin

Indexed keywords

KETAMINE; SNARE PROTEIN; SYNAPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SINGLE DRUG DOSE; SYNAPTOSOME;

EID: 84877148445     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.03.008     Document Type: Article

References (55)

1. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95.
2. Bagley J., Moghaddam B. Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam. Neuroscience 1997, 77:65-73.
3. Banasr M., Chowdhury G.M., Terwilliger R., Newton S.S., Duman R.S., Behar K.L., et al. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Molecular Psychiatry 2010, 15:501-511.
4. Barbiero V.S., Giambelli R., Musazzi L., Tiraboschi E., Tardito D., Perez J., et al. Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychopharmacology 2007, 32:2511-2519.
5. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., et al. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 2000, 47:351-354.
6. Beurel E., Song L., Jope R.S. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Molecular Psychiatry 2011, 16:1068-1070.
7. Bonanno G., Giambelli R., Raiteri L., Tiraboschi E., Zappettini S., Musazzi L., et al. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. Journal of Neuroscience 2005, 25:3270-3279.
8. Chapman E.R. How does synaptotagmin trigger neurotransmitter release?. Annual Review of Biochemistry 2008, 77:615-641.
9. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 2002, 23:238-245.
10. Cui X., Li J., Li T., Ji F., Bu X., Zhang N., et al. Propofol and ketamine-induced anesthetic depth-dependent decrease of CaMKII phosphorylation levels in rat hippocampus and cortex. Journal of Neurosurgical Anesthesiology 2009, 21:145-154.
11. Dulubova I., Khvotchev M., Liu S., Huryeva I., Südhof T.C., Rizo J. Munc18-1 binds directly to the neuronal SNARE complex. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:2697-2702.
12. Dulubova I., Sugita S., Hill S., Hosaka M., Fernandez I., Südhof T.C., et al. A conformational switch in syntaxin during exocytosis: role of munc18. The EMBO Journal 1999, 18:4372-4382.
13. Elfving B., Bonefeld B.E., Rosenberg R., Wegener G. Differential expression of synaptic vesicle proteins after repeated electroconvulsive seizures in rat frontal cortex and hippocampus. Synapse 2008, 62:662-670.
14. Fatemi S.H., Earle J.A., Stary J.M., Lee S., Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 2001, 12:3257-3262.
15. Fdez E., Hilfiker S. Vesicle pools and synapsins: new insights into old enigmas. Brain Cell Biology 2006, 35:107-115.
16. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochemical Journal 2001, 359:1-16.
17. Gao Y., Bezchlibnyk Y.B., Sun X., Wang J.F., McEwen B.S., Young L.T. Effects of restraint stress on the expression of proteins involved in synaptic vesicle exocytosis in the hippocampus. Neuroscience 2006, 141:1139-1148.
18. Garcia L.S., Comim C.M., Valvassori S.S., Reus G.Z., Barbosa L.M., Andreazza A.C., et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:140-144.
19. Gilad G.M., Gilad V.H., Wyatt R.J., Tizabi Y. Region-selective stress-induced increase of glutamate uptake and release in rat forebrain. Brain Research 1990, 525:335-338.
20. Hascup E.R., Hascup K.N., Stephens M., Pomerleau F., Huettl P., Gratton A., et al. Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. Journal of Neurochemistry 2010, 115:1608-1620.
21. Hascup K.N., Hascup E.R., Stephens M.L., Glaser P.E., Yoshitake T., Mathe A.A., et al. Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the flinders sensitive line rat: a genetic rodent model of depression. Neuropsychopharmacology 2011, 36:1769-1777.
22. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Research Reviews 2009, 61:105-123.
23. Hayashi T., McMahon H., Yamasaki S., Binz T., Hata Y., Südhof T.C., et al. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. The EMBO Journal 1994, 13:5051-5061.
24. Kapur S., Seeman P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Molecular Psychiatry 2002, 7:837-844.
25. Karst H., Berger S., Turiault M., Tronche F., Schutz G., Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:19204-19207.
26. Leroy K., Brion J.P. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. Journal of Chemical Neuroanatomy 1999, 16:279-293.
27. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
28. Li N., Liu R.J., Dwyer J.M., Banasr M., Lee B., Son H., et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry 2011, 69:754-761.
29. Lonart G., Südhof T.C. Assembly of SNARE core complexes prior to neurotransmitter release sets the readily releasable pool of synaptic vesicles. The Journal of Biological Chemistry 2000, 275:27703-27707.
30. Lorrain D.S., Baccei C.S., Bristow L.J., Anderson J.J., Varney M.A. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 2003, 117:697-706.
31. Lowy M.T., Wittenberg L., Yamamoto B.K. Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. Journal of Neurochemistry 1995, 65:268-274.
32. Machado-Vieira R., Salvadore G., Ibrahim L.A., Diaz-Granados N., Zarate C.A. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders. Current Pharmaceutical Design 2009, 15:1595-1611.
33. Maeng S., Zarate C.A., Du J., Schloesser R.J., McCammon J., Chen G., et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biological Psychiatry 2008, 63:349-352.
34. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. The Journal of Neuroscience 1997, 17:2921-2927.
35. Moghaddam B., Bolinao M.L., Stein-Behrens B., Sapolsky R. Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Research 1994, 655:251-254.
36. Müller H.K., Wegener G., Popoli M., Elfving B. Differential expression of synaptic proteins after chronic restraint stress in rat prefrontal cortex and hippocampus. Brain Research 2011, 1385:26-37.
37. Musazzi L., Milanese M., Farisello P., Zappettini S., Tardito D., Barbiero V.S., et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS.One 2010, 5:e8566.
38. Nishimura M., Sato K., Okada T., Yoshiya I., Schloss P., Shimada S., et al. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 1998, 88:768-774.
39. Nomura K., Ohyama A., Komiya Y., Igarashi M. Minimal residues in linker domain of syntaxin 1A required for binding affinity to Ca2+/calmodulin-dependent protein kinase II. Journal of Neuroscience Research 2003, 72:198-202.
40. Ohyama A., Hosaka K., Komiya Y., Akagawa K., Yamauchi E., Taniguchi H., et al. Regulation of exocytosis through Ca2+/ATP-dependent binding of autophosphorylated Ca2+/calmodulin-activated protein kinase II to syntaxin 1A. The Journal of Neuroscience 2002, 22:3342-3351.
41. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
42. Popoli M., Mori S., Brunello N., Perez J., Gennarelli M., Racagni G. Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders. Pharmacology & Therapeutics 2001, 89:149-170.
43. Rapp S., Baader M., Hu M., Jennen-Steinmetz C., Henn F.A., Thome J. Differential regulation of synaptic vesicle proteins by antidepressant drugs. The Pharmacogenomics Journal 2004, 4:110-113.
44. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
45. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biological Psychiatry 2000, 48:755-765.
46. Scarr E., Gray L., Keriakous D., Robinson P.J., Dean B. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disorders 2006, 8:133-143.
47. Shen J., Tareste D.C., Paumet F., Rothman J.E., Melia T.J. Selective activation of cognate SNAREpins by Sec1/Munc18 proteins. Cell 2007, 128:183-195.
48. Südhof T.C. The synaptic vesicle cycle. Annual Review of Neuroscience 2004, 27:509-547.
49. Valtorta F., Pozzi D., Benfenati F., Fornasiero E.F. The synapsins: multitask modulators of neuronal development. Seminars in Cell & Developmental Biology 2011, 22:378-386.
50. Verona M., Zanotti S., Schafer T., Racagni G., Popoli M. Changes of synaptotagmin interaction with t-SNARE proteins in vitro after calcium/calmodulin-dependent phosphorylation. Journal of Neurochemistry 2000, 74:209-221.
51. Wang Z.W. Regulation of synaptic transmission by presynaptic CaMKII and BK channels. Molecular Neurobiology 2008, 38:153-166.
52. Yamada M., Takahashi K., Tsunoda M., Nishioka G., Kudo K., Ohata H., et al. Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics Journal 2002, 2:377-382.
53. Yang B., Steegmaier M., Gonzalez L.C., Scheller R.H. nSec1 binds a closed conformation of syntaxin1A. The Journal of Cell Biology 2000, 148:247-252.
54. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 2006, 63:856-864.
55. Zhu L.Q., Liu D., Hu J., Cheng J., Wang S.H., Wang Q., et al. GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation. The Journal of Neuroscience 2010, 30:3624-3633.